Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 2 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| Mar 15 | ANIK | Anika Therapeutics, Inc. | MEXER | 6,449 | — | — | +10.2% | Open the original filing on SEC.gov |
| Mar 14 | ANIK | Anika Therapeutics, Inc. | MEXER◆ | 9,388 | — | — | — | Open the original filing on SEC.gov |
| Mar 14 | ANIK | Anika Therapeutics, Inc. | FTAX | 4,168 | $14.20 | $59.2K | -6.2% | Open the original filing on SEC.gov |
| Mar 14 | ANIK | Anika Therapeutics, Inc. | AGRANT | 4,694 | — | — | +7.5% | Open the original filing on SEC.gov |
| Mar 14 | ANIK | Anika Therapeutics, Inc. | MEXER | 9,388 | — | — | +17.7% | Open the original filing on SEC.gov |
| Mar 9 | ANIK | Anika Therapeutics, Inc. | MEXER◆ | 5,465 | — | — | — | Open the original filing on SEC.gov |
| Mar 9 | ANIK | Anika Therapeutics, Inc. | FTAX | 1,919 | $14.96 | $28.7K | -3.5% | Open the original filing on SEC.gov |
| Mar 9 | ANIK | Anika Therapeutics, Inc. | MEXER | 5,465 | — | — | +11.0% | Open the original filing on SEC.gov |